|
|
|
|
α1D-adrenoceptor
|
|
|
Rn |
Agonist |
Full agonist |
6.3 |
pKi |
- |
16 |
|
| ⤷ |
pKi
6.3
[16]
|
|
α1D-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
5.3 – 7.2 |
pKi |
- |
13,20,22 |
|
| ⤷ |
pKi
5.3 – 7.2
[13,20,22]
|
|
α1A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
5.1 – 6.5 |
pKi |
- |
13,20-22 |
|
| ⤷ |
pKi
5.1 – 6.5
[13,20-22]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
5.4 – 6.2 |
pKi |
- |
4,7,11-12,14,23 |
|
| ⤷ |
pKi
5.4 – 6.2
[4,7,11-12,14,23]
|
|
α2A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.7 – 7.4 |
pKi |
- |
15,18-19 |
|
| ⤷ |
pKi
3.7 – 7.4
[15,18-19]
|
|
α2C-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
4.9 – 5.8 |
pKi |
- |
15,19 |
|
| ⤷ |
pKi
4.9 – 5.8
[15,19]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
4.7 – 6.0 |
pKi |
- |
4,6-7,11-12,23 |
|
| ⤷ |
pKi
4.7 – 6.0
[4,6-7,11-12,23]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Agonist |
5.3 |
pKi |
- |
8,17,23 |
|
| ⤷ |
pKi
5.3
[8,17,23]
|
|
α1B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.9 – 6.5 |
pKi |
- |
20,22 |
|
| ⤷ |
pKi
3.9 – 6.5
[20,22]
|
|
α2B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.6 – 5.2 |
pKi |
- |
15,19 |
|
| ⤷ |
pKi
3.6 – 5.2
[15,19]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.9 – 4.7 |
pKi |
- |
3-4,8,12,23,25 |
|
| ⤷ |
pKi
3.9 – 4.7
[3-4,8,12,23,25]
|
|
α1B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
9.4 |
pEC50 |
- |
20 |
|
| ⤷ |
pEC50
9.4
[20]
|
|
α1A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
9.1 |
pEC50 |
- |
20 |
|
| ⤷ |
pEC50
9.1
[20]
|
|
α1D-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
7.7 |
pEC50 |
- |
20 |
|
| ⤷ |
pEC50
7.7
[20]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
6.8 – 8.4 |
pEC50 |
- |
4-5,9 |
|
| ⤷ |
pEC50
6.8 – 8.4
[4-5,9]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Agonist |
7.5 – 7.6 |
pEC50 |
- |
8,17 |
|
| ⤷ |
pEC50
7.5 – 7.6
[8,17]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
6.7 – 7.6 |
pEC50 |
- |
2,4,6 |
|
| ⤷ |
pEC50
6.7 – 7.6
[2,4,6]
|
|
β1-adrenoceptor
|
|
|
Mg |
Agonist |
Agonist |
7.1 |
pEC50 |
- |
3 |
|
| ⤷ |
pEC50
7.1
[3]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
6.5 – 7.3 |
pEC50 |
- |
1,4,8 |
|
| ⤷ |
pEC50
6.5 – 7.3
[1,4,8]
|
|
α2B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
7.6 |
pIC50 |
- |
19 |
|
| ⤷ |
pIC50
7.6
[19]
Description: inhibition of forskolin stimulated cAMP generation
|
|
α2C-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
6.7 |
pIC50 |
- |
19 |
|
| ⤷ |
pIC50
6.7
[19]
Description: inhibition of cAMP production
|
|
α2A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
6.5 |
pIC50 |
- |
19 |
|
| ⤷ |
pIC50
6.5
[19]
Description: inhibition of forskolin stimulated cAMP generation
|
|